Home Healthcare Biotechnology Neurological Biomarkers Market

Neurological Biomarkers Market Size, Share & Trends Analysis Report By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By Applications (Alzheimer's Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End-User (Hospitals and Hospital Laboratories, Independent Clinical Diagnostic Centers, Research Organizations and Other) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR4646DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Neurological Biomarkers Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Genomic
    2. Proteomic
    3. Metabolomic
    4. Imaging
    5. Others
  2. Neurological Biomarkers Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Alzheimer's Disease
    2. Parkinson’s Disease
    3. Multiple Sclerosis
    4. Autism Spectrum Disorders
    5. Others
  3. Neurological Biomarkers Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals and Hospital Laboratories
    2. Independent Clinical Diagnostic Centers
    3. Research Organizations and Other
  4. Regional Neurological Biomarkers Market
    1. North America
      1. North America Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genomic
        2. Proteomic
        3. Metabolomic
        4. Imaging
        5. Others
      2. North America Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. North America Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Hospital Laboratories
        2. Independent Clinical Diagnostic Centers
        3. Research Organizations and Other
      4. U.S. Neurological Biomarkers Market
        1. U.S. Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. U.S. Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. U.S. Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      5. Canada Neurological Biomarkers Market
        1. Canada Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Canada Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Canada Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
    2. Europe
      1. Europe Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genomic
        2. Proteomic
        3. Metabolomic
        4. Imaging
        5. Others
      2. Europe Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. Europe Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Hospital Laboratories
        2. Independent Clinical Diagnostic Centers
        3. Research Organizations and Other
      4. U.K. Neurological Biomarkers Market
        1. U.K. Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. U.K. Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. U.K. Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      5. Germany Neurological Biomarkers Market
        1. Germany Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Germany Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Germany Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      6. France Neurological Biomarkers Market
        1. France Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. France Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. France Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      7. Spain Neurological Biomarkers Market
        1. Spain Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Spain Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Spain Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      8. Italy Neurological Biomarkers Market
        1. Italy Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Italy Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Italy Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      9. Russia Neurological Biomarkers Market
        1. Russia Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Russia Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Russia Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      10. Nordic Neurological Biomarkers Market
        1. Nordic Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Nordic Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Nordic Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      11. Benelux Neurological Biomarkers Market
        1. Benelux Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Benelux Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Benelux Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      12. Rest of Europe Neurological Biomarkers Market
        1. Rest of Europe Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Rest of Europe Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Rest of Europe Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
    3. APAC
      1. APAC Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genomic
        2. Proteomic
        3. Metabolomic
        4. Imaging
        5. Others
      2. APAC Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. APAC Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Hospital Laboratories
        2. Independent Clinical Diagnostic Centers
        3. Research Organizations and Other
      4. China Neurological Biomarkers Market
        1. China Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. China Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. China Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      5. Korea Neurological Biomarkers Market
        1. Korea Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Korea Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Korea Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      6. Japan Neurological Biomarkers Market
        1. Japan Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Japan Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Japan Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      7. India Neurological Biomarkers Market
        1. India Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. India Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. India Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      8. Australia Neurological Biomarkers Market
        1. Australia Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Australia Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Australia Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      9. Taiwan Neurological Biomarkers Market
        1. Taiwan Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Taiwan Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Taiwan Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      10. South East Asia Neurological Biomarkers Market
        1. South East Asia Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. South East Asia Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. South East Asia Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      11. Rest of Asia-Pacific Neurological Biomarkers Market
        1. Rest of Asia-Pacific Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Rest of Asia-Pacific Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Rest of Asia-Pacific Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
    4. Middle East and Africa
      1. Middle East and Africa Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genomic
        2. Proteomic
        3. Metabolomic
        4. Imaging
        5. Others
      2. Middle East and Africa Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. Middle East and Africa Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Hospital Laboratories
        2. Independent Clinical Diagnostic Centers
        3. Research Organizations and Other
      4. UAE Neurological Biomarkers Market
        1. UAE Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. UAE Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. UAE Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      5. Turkey Neurological Biomarkers Market
        1. Turkey Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Turkey Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Turkey Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      6. Saudi Arabia Neurological Biomarkers Market
        1. Saudi Arabia Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Saudi Arabia Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Saudi Arabia Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      7. South Africa Neurological Biomarkers Market
        1. South Africa Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. South Africa Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. South Africa Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      8. Egypt Neurological Biomarkers Market
        1. Egypt Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Egypt Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Egypt Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      9. Nigeria Neurological Biomarkers Market
        1. Nigeria Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Nigeria Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Nigeria Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      10. Rest of MEA Neurological Biomarkers Market
        1. Rest of MEA Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Rest of MEA Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Rest of MEA Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
    5. LATAM
      1. LATAM Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genomic
        2. Proteomic
        3. Metabolomic
        4. Imaging
        5. Others
      2. LATAM Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Alzheimer's Disease
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Autism Spectrum Disorders
        5. Others
      3. LATAM Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Hospital Laboratories
        2. Independent Clinical Diagnostic Centers
        3. Research Organizations and Other
      4. Brazil Neurological Biomarkers Market
        1. Brazil Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Brazil Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Brazil Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      5. Mexico Neurological Biomarkers Market
        1. Mexico Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Mexico Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Mexico Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      6. Argentina Neurological Biomarkers Market
        1. Argentina Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Argentina Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Argentina Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      7. Chile Neurological Biomarkers Market
        1. Chile Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Chile Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Chile Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      8. Colombia Neurological Biomarkers Market
        1. Colombia Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Colombia Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Colombia Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
      9. Rest of LATAM Neurological Biomarkers Market
        1. Rest of LATAM Neurological Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
          1. Genomic
          2. Proteomic
          3. Metabolomic
          4. Imaging
          5. Others
        2. Rest of LATAM Neurological Biomarkers Market By Applications 2022-2034 (USD MILLION/ Units)
          1. Alzheimer's Disease
          2. Parkinson’s Disease
          3. Multiple Sclerosis
          4. Autism Spectrum Disorders
          5. Others
        3. Rest of LATAM Neurological Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Hospitals and Hospital Laboratories
          2. Independent Clinical Diagnostic Centers
          3. Research Organizations and Other
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.